OCT 6, 2026 · JOURNAL ARTICLE
Specialist-led community-based cardio-kidney-metabolic-pulmonary care in high risk individuals: multi-centre pragmatic prospective randomised open label blinded endpoint trial
European Heart Journal Open
Abstract Background and Aims Pharmacological therapies that treat cardiovascular, kidney, metabolic and pulmonary (CKMP) risk factors reduce the risk of major adverse cardiovascula